2310263-59-1
Chemical Structure
P2X3 antagonist 36
- CAS No.: 2310263-59-1
- Formula:C20H18ClF3N6O3
- Molecular Weight:482.84
IUPAC Name: (R)-2-(6-(sec-butyl)-5,8-dioxo-2-(trifluoromethyl)-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidin-4-yl)-N-(5-chloropyridin-2-yl)acetamide
InChIKey: AHDQSCWTJUABRN-SNVBAGLBSA-N
SMILES: O=C(NC1=NC=C(Cl)C=C1)CN(C2=C3CN([C@H](C)CC)C2=O)C4=CC(C(F)(F)F)=NN4C3=O
Biological Activity: P2X3 antagonist 36 is a P2X3 antagonist extracted from patent WO2019081343A1 compound 156[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
P2X3 antagonist 36 | P2X3 antagonist 36 is a P2X3 antagonist extracted from patent WO2019081343A1 compound 156. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords